Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction
Authors
Keywords
oxazolones, dispiro indolinones, 1,3-dipolar cycloaddition, cytotoxicity
Journal
RUSSIAN CHEMICAL BULLETIN
Volume 67, Issue 3, Pages 562-569
Publisher
Springer Nature
Online
2018-06-26
DOI
10.1007/s11172-018-2111-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Organic chemistry. History and mutual relations of universities of Russia
- (2017) I. S. Antipin et al. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY
- Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction
- (2016) Andreas Gollner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological testing of (5Z)-2-aryl-5-arylmethylidene-3,5-dihydro-4H-imidazol-4-ones as antimitotic agents
- (2016) Anastasia A. Beloglazkina et al. MEDICINAL CHEMISTRY RESEARCH
- Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors
- (2015) Yan A. Ivanenkov et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The discovery of oxazolones-grafted spirooxindoles via three-component diversity oriented synthesis and their preliminary biological evaluation
- (2015) Hui Dong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Computational analysis of spiro-oxindole inhibitors of the MDM2-p53 interaction: insights and selection of novel inhibitors
- (2015) Wei Huang et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Synthesis and biotests of 2-aryl-5-arylmethylidene-substituted 1,3-oxazol-5(4H)-ones and N-methyl-3,5-dihydro-4H-imidazol-4-ones as combretastatin A-4 analogs
- (2015) E. S. Barskaia et al. RUSSIAN CHEMICAL BULLETIN
- Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy
- (2014) Zhuming Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression
- (2014) S. Wang et al. CANCER RESEARCH
- Recent advances in the synthesis of biologically active spirooxindoles
- (2014) Maria M.M. Santos TETRAHEDRON
- Efficient and Regioselective Synthesis of Novel Functionalized Dispiropyrrolidines and Their Cytotoxic Activities
- (2014) Jin-Ming Yang et al. ACS Combinatorial Science
- Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors
- (2013) Yujun Zhao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synthesis of a Spiroindolinone Pyrrolidinecarboxamide MDM2 Antagonist
- (2013) Lianhe Shu et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development
- (2013) Zhuming Zhang et al. ACS Medicinal Chemistry Letters
- DNA methylation inhibitors in cancer: Recent and future approaches
- (2012) Christina Gros et al. BIOCHIMIE
- Excited-State Intramolecular Proton Transfer Molecules Bearingo-Hydroxy Analogues of Green Fluorescent Protein Chromophore
- (2011) Wei-Ti Chuang et al. JOURNAL OF ORGANIC CHEMISTRY
- Identification of the Spiro(oxindole-3,3′-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators
- (2010) Isabel Gomez-Monterrey et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More